CNBX PHARMACEUTICALS INC. Stock Issued During Period, Shares, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CNBX PHARMACEUTICALS INC. stock issued during period, shares, conversion of convertible securities for the quarter ending 2025-11-30 was 199.23M shares.
| Period end | Stock Issued During Period, Shares, Conversion of Convertible Securities 3 month | Stock Issued During Period, Shares, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2025-11-30 | 199.23M shares 10-Q · filed 2026-01-14 | |
| 2014-08-31 | 40.00M shares 10-Q/A · filed 2015-11-17 |